You have accessJournal of UrologyProstate Cancer: Detection & Screening V1 Apr 2018MP57-15 ASSESSING PRIMARY CARE PATTERNS FOR PROSTATE SPECIFIC ANTIGEN SCREENING IN AN INNER CITY, INDIGENT POPULATION Jyoti Chouhan, John Sullivan, Melissa Lee, Anthony Sorrentino, Abdo Kabaritti, and Andrew Winer Jyoti ChouhanJyoti Chouhan More articles by this author , John SullivanJohn Sullivan More articles by this author , Melissa LeeMelissa Lee More articles by this author , Anthony SorrentinoAnthony Sorrentino More articles by this author , Abdo KabarittiAbdo Kabaritti More articles by this author , and Andrew WinerAndrew Winer More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.1827AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Primary care providers (PCPs) provide their male patients with information and recommendations regarding prostate specific antigen (PSA) testing. Little is known regarding what factors affect their PSA screening preferences in an indigent, high risk and underserved setting after the 2012 United States Preventative Services Task Force (USPSTF) recommendation. METHODS A 24 question survey was created and distributed to PCPs at a single, tertiary, academic, inner city, county hospital in Brooklyn, New York. RESULTS A total of 41 responses were obtained: 19 males (46.3%), 21 females (51.2%) and 1 preferred not to answer. Most respondents practiced internal medicine (n= 31/40, 77.5%), were an attending physician (n=22/39, 56.4%) or resident physician (n= 10, 25.6%). The main patient populations served were Afro-Caribbean (AC), African American (AA) and Hispanic. The majority of providers cited government based guidelines as their primary means of altering their medical decision-making (n = 33/42, 78.6%) and noted that the 2012 USPSTF recommendations for PSA based screening did not change their practice (n=22/38, 57.9%). For those whose decision changed, it did so primarily by having a shared decision making process with the patient (n = 18/30, 60%). Most providers had little familiarity with PSA recommendations from other organizations (e.g., The American Urological Association). When asked if their practice would change if the USPSTF changed their PSA screening recommendation from a Category D to C, most felt unsure (n = 21/40, 52.5%). However, if it were to change from a Category D to A or B, the majority would change their current practice (n = 30/40, 75%). On a scale of 1-5, the majority of providers felt that race and a positive family history strongly influenced (>/= 4/5) their PSA screening decisions as well (n = 23/41, 56.1% and n = 30/41, 73.2%, respectively). On a scale of 1-5, several providers strongly felt (>/= 4/5) that not routinely recommending PSA screening could lead to future litigation regarding failure to diagnose disease (n = 17/41, 41.5%). CONCLUSIONS PCPs at an academic, inner city, county hospital rely heavily on government based screening recommendations to help in their decision making. However, most providers did not change their PSA screening practices despite a USPSTF Category D recommendation in this high risk population. Positive family history and race play a strong role in their recommending PSA based screening to this predominantly AC and AA based population regardless of the current USPSTF recommendation. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e770 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Jyoti Chouhan More articles by this author John Sullivan More articles by this author Melissa Lee More articles by this author Anthony Sorrentino More articles by this author Abdo Kabaritti More articles by this author Andrew Winer More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Read full abstract